/Merck%20%26%20Co%20Inc%20billboard-by%20monticello%20via%20Shutterstock.jpg)
Rahway, New Jersey-based Merck & Co., Inc. (MRK) operates as a healthcare company worldwide. Valued at $256.4 billion by market cap, the company delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.
Companies worth $200 billion or more are generally described as “mega-cap stocks,” and MRK definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the general drug manufacturers industry. Merck is a leader in research and development, with a strong focus on discovering and developing new drugs and vaccines. Through collaborations with academic institutions, biotech firms, and other pharmaceutical companies, Merck maintains a robust pipeline in multiple therapeutic areas. With products like Keytruda and Gardasil, Merck has established itself as a global leader.